Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients | Drug Metabolism & Disposition
Dose levels of irinotecan, dose actually delivered and dose intensity | Download Table
irinotecan
Irinotecan Pathway, Pharmacokinetics
Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study | BMC Cancer | Full Text
ONIVYDE Dosage & Rx Info | Uses, Side Effects
Cost–effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer | Pharmacogenomics
Irinotecan: Package Insert - Drugs.com
First-Line Liposomal Irinotecan–Containing Regimen Studied in Advanced Pancreatic Cancer - The ASCO Post
Approved for use in:
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs - Milano - 2022 - Cancer Science - Wiley Online Library
Irinotecan dose escalation according to the UGT1A1 genotype | Download Table
DEP® irinotecan synergistic with Lynparza® in refractory human colon cancer model | BioMelbourne Network
DBL Irinotecan Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
JCM | Free Full-Text | Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients
Irinotecan: Package Insert - Drugs.com
UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study | British Journal of Cancer
Know Irinotecan price | Buy Iritero
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised ...
Irinotecan Actavis
Pfizer Hospital US
IJMS | Free Full-Text | Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview